Status:
COMPLETED
Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response
Lead Sponsor:
Yuan-hong Gao
Collaborating Sponsors:
Sixth Affiliated Hospital, Sun Yat-sen University
Peking University Cancer Hospital & Institute
Conditions:
Rectal Cancer
Organ Preservation
Eligibility:
All Genders
16-90 years
Brief Summary
This was a propensity-score matched observational analysis, comparing the oncological outcome of surgical resection vs watch and wait apporach for rectal cancer patients with a cCR.
Detailed Description
Pathologically confirmed stage II/III rectal adenocarcinoma patients who received neoadjuvant chemoradiotherapy followed by a clinical complete response from the year 2010 to 2018 were included. Seque...
Eligibility Criteria
Inclusion
- Pathologically confirmed stage II/III rectal adenocarcinoma patients who received neoadjuvant chemoradiotherapy followed by a clinical complete response
Exclusion
- history of a second primary malignancy.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
513 Patients enrolled
Trial Details
Trial ID
NCT03846726
Start Date
January 1 2018
End Date
February 28 2019
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060